Molly Kerrigan

Associate Director, Global Patient Safety, AstraZeneca

Molly Kerrigan is an Associate Director in Patient Safety Data & Analytics at AstraZeneca, where she leads data-driven initiatives focused on clinical trial representation, health equity, and safety contextualization. In her role, she leverages real-world and clinical trial data to better understand disease burden, demographics of patient populations, and safety outcomes. Her work includes developing internal tools to enable teams to monitor the representativeness of their clinical trial participant populations to quantify unmet need and identify opportunities to improve representation and equity in clinical trials. She collaborates with teams across patient safety, patient centricity, epidemiology, clinical development, clinical operations, and regulatory affairs to translate data into actionable insights to support teams in making evidence-based and equity-driven decisions on their clinical programs. Molly is particularly passionate about data-driven advancements to health equity and representative clinical trials, helping the organization understand how disease prevalence, access, and clinical trial participation can vary across demographic groups, inform representative research, and support better health outcomes for patients.